BIOGEN INC (BIIB)

Currency USD

Company Overview

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders including Parkinson's disease, neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) and ophthalmology. Key multiple sclerosis/MS drugs in its portfolio are Tecfidera, Vumerity, Avonex, Plegridy, Fampyra and Tysabri. Other approved/marketed products include Fumaderm (severe psoriasis), Spinraza (spinal muscular atrophy (SMA)) and Aduhelm (Alzheimer's disease).

Contact Details

Address: 225 BINNEY STREET
City: CAMBRIDGE
State: MA
Country: USA
Zip Code: 02142
Phone Number: 617-679-2000
Website: -

Financial Highlights

Day Range The price range a stock has traded at during the most recent trading period.: -

-
5 Day Range The price range a stock has traded at during the previous 5 days.: -

-
3 Month Range The price range a stock has traded at during the previous 3 months.: -

-
52 Week Range The price range a stock has traded at during the previous 52 weeks.: -

-
Previous Close The closing price of a stock from the previous day.: -
Open The price of the stock at the start of today’s market opening.: -
Bid The amount of money a trader is willing to pay per share for a given stock.: x
-
Ask The amount of money a seller wants per share of a given stock.: x
-
Volume The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.: -
Avg. Volume The average number of shares traded in a given day.: -
Dividend Yield A company's annual dividend expressed as a percentage of its current stock price.: -
Recent Dividend The value a shareholder receives from a company they are invested in for holding their shares.: -
Beta A measurement of the stock’s volatility in comparison to the market as a whole.: -

Shareholding

Shares Outstanding Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.: -
Insider Shareholders The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.: -
Institutional Shareholders The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.: -

Market Cap The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.: -
Revenue TTM The amount of money a company has made for the trailing twelve-month period.: -
Net Income TTM A measurement of how much profit they are retaining for the trailing twelve-month period.: -
P/E Ratio The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.: -
EPS TTM Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.: -
1 Year Return A measurement of how much the stock has increased or decreased in the last year.: -